Meda says rejects Mylan proposal to buy it
STOCKHOLM, April 4
STOCKHOLM, April 4 (Reuters) - Swedish drug maker Meda said on Friday U.S. generics firm Mylan had contacted Meda and proposed to buy it but that the board had rejected the indicative proposal.
"All continued discussions between Meda and Mylan have been terminated without further actions," Meda said in statement.
Shares in Meda were halted on Friday following media reports that Mylan was looking into buying it. (Reporting by Sven Nordenstam)
- Tape emerges of Clinton discussing bin Laden day before 9/11 attack
- Gaza truce over, Israel soldier captured, 70 dead in Rafah shelling |
- Financial health: The four numbers to zero in on
- Ebola patient coming to U.S. as aid workers' health worsens
- Sierra Leone declares emergency as Ebola death toll hits 729 |